# OnCo record paolo-ascierto (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/paolo-ascierto/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "paolo-ascierto" ;
  schema:name "Paolo A. Ascierto"@en ;
  schema:description "Italian melanoma oncologist who co-led CheckMate 238, CheckMate 067 and the COLUMBUS BRAF/MEK trial."@en ;
  schema:url <https://onco.cc/people/paolo-ascierto/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Ascierto%20PA%5BAuthor%5D%20melanoma> ;
  onco:tag "melanoma", "immunotherapy", "italy" ;
  schema:jobTitle "Director, Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/braf/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/encorafenib/> ;
  onco:institutions <https://onco.cc/institutions/pascale-naples/> ;
  onco:trials <https://onco.cc/trials/columbus/>, <https://onco.cc/trials/checkmate-067/> ;
  schema:affiliation <https://onco.cc/institutions/pascale-naples/> .